Generation of two isogenic iPSC lines from a healthy male donor of European ancestry

Generation of two isogenic iPSC lines from a healthy male donor of European ancestry

We have created two isogenic iPSC lines from fibroblasts of a healthy male donor of European ancestry. The cell lines express common pluripotency markers, are free of chromosomal aberrations and are able to differentiate into cells of all three germ layers. These iPSC are now a resource for genome e...

Full description

Bibliographic Details
Main Authors:	S. Edwards, L. Hagenau, B. Nowack, J. Rhode, M.F. Hossain, A. Tzvetkova, L.R. Jensen, A.W. Kuss
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506124001016

Similar Items

Generation of two iPSC lines (MHHi001-A-12 and MHHi001-A-13) carrying biallelic truncating mutations at the 3′-end of SRCAP using CRISPR/Cas9
by: J. Rhode, et al.
Published: (2023-12-01)

Modeling mutation-specific arrhythmogenic phenotypes in isogenic human iPSC-derived cardiac tissues
by: Thomas L. Maurissen, et al.
Published: (2024-01-01)

Generation of two human isogenic iPSC lines from fetal dermal fibroblasts
by: Rashmi Tandon, et al.
Published: (2018-12-01)

Generation of a CHIP isogenic human iPSC-derived cortical neuron model for functional proteomics
by: Catarina Dias, et al.
Published: (2022-06-01)

Brain microvascular endothelial cell dysfunction in an isogenic juvenile iPSC model of Huntington’s disease
by: Raleigh M. Linville, et al.
Published: (2022-06-01)

Generation and Evaluation of Isogenic iPSC as a Source of Cell Replacement Therapies in Patients with Kearns Sayre Syndrome
by: Glen Lester Sequiera, et al.
Published: (2021-03-01)

Generation of three human iPSC lines from patients with Huntington’s disease with different CAG lengths and human control iPSC line from a healthy donor
by: Ewelina Latoszek, et al.
Published: (2022-10-01)

Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors
by: Katerina Vlahos, et al.
Published: (2023-06-01)

Development of a human iPSC line (SMBCi017-A) from a healthy donor
by: Zhenzhong Han, et al.
Published: (2022-08-01)

Establishment of a human iPSC line (SUTCMi001-A) derived from a healthy donor
by: Lingyuan Min, et al.
Published: (2022-08-01)

Generation of control human iPSC line INSTEMi001-A from PBMCs of a healthy Indian donor
by: Niharika Patlolla, et al.
Published: (2023-06-01)

Establishment of two iPSC lines from healthy donor with heterozygous mutation in the SLC26A4 gene
by: SiJun Li, et al.
Published: (2022-10-01)

Identifying Extrinsic versus Intrinsic Drivers of Variation in Cell Behavior in Human iPSC Lines from Healthy Donors
by: Alessandra Vigilante, et al.
Published: (2019-02-01)

Generation and characterization of two iPSC lines from human adipose tissue-derived stem cells of healthy donors
by: Xiang-Bin Zhou, et al.
Published: (2020-10-01)

Isogenic Human iPSC Parkinson’s Model Shows Nitrosative Stress-Induced Dysfunction in MEF2-PGC1α Transcription
by: Ryan, Scott D., et al.
Published: (2016)

Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy
by: Nele Warnecke, et al.
Published: (2021-08-01)

Mitochondrial Alterations by PARKIN in Dopaminergic Neurons Using PARK2 Patient-Specific and PARK2 Knockout Isogenic iPSC Lines
by: Atossa Shaltouki, et al.
Published: (2015-05-01)

Generating an iPSC line (with isogenic control) from the PBMCs of an ACTA1 (p.Gly148Asp) nemaline myopathy patient
by: Peter J. Houweling, et al.
Published: (2021-07-01)

Aberrant Splicing of <i>INS</i> Impairs Beta-Cell Differentiation and Proliferation by ER Stress in the Isogenic iPSC Model of Neonatal Diabetes
by: Alexandra V. Panova, et al.
Published: (2022-08-01)

Isogenic FUS-eGFP iPSC Reporter Lines Enable Quantification of FUS Stress Granule Pathology that Is Rescued by Drugs Inducing Autophagy
by: Lara Marrone, et al.
Published: (2018-02-01)

Generation of two isogenic iPSC lines with either a heterozygous or a homozygous E280A mutation in the PSEN1 gene
by: Henriette R. Frederiksen, et al.
Published: (2019-03-01)

Comparisons of dual isogenic human iPSC pairs identify functional alterations directly caused by an epilepsy associated SCN1A mutation
by: Yunyao Xie, et al.
Published: (2020-02-01)

Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line
by: Benjamin Schmid, et al.
Published: (2019-01-01)

Generation of four integration-free iPSC lines from related human donors
by: Anja Patricia Ramme, et al.
Published: (2019-12-01)

The CIRM iPSC repository
by: Stephen S. Lin, et al.
Published: (2020-04-01)

CiRA iPSC seed stocks (CiRA's iPSC Stock Project)
by: Tadaaki Hanatani, et al.
Published: (2021-01-01)

Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variant
by: Nikita Kozhushko, et al.
Published: (2023-06-01)

Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model.
by: Gene Ananiev, et al.
Published: (2011-01-01)

Establishment and characterization of two iPSC lines derived from healthy controls
by: Achchhe Patel, et al.
Published: (2020-08-01)

Generation of two additional integration-free iPSC lines from related human donors
by: Anja Patricia Ramme, et al.
Published: (2021-05-01)

The utilisation of hydrogels for iPSC-cardiomyocyte research
by: Patel, L, et al.
Published: (2023)

Generation and characterization of a human iPSC line and gene-corrected isogenic line derived from a patient with a CELF2 gene mutation
by: Michelle Hua, et al.
Published: (2024-04-01)

Modeling native and seeded Synuclein aggregation and related cellular dysfunctions in dopaminergic neurons derived by a new set of isogenic iPSC lines with SNCA multiplications
by: Angelo Iannielli, et al.
Published: (2022-10-01)

Generation of two human iPSC lines from dermal fibroblasts of adult- and juvenile-onset Huntington's disease patients and two healthy donors
by: Marta Piechota, et al.
Published: (2023-09-01)

The Global Alliance for iPSC Therapies (GAiT)
by: Stephen Sullivan, et al.
Published: (2020-12-01)

Parallel derivation of X-monosomy induced pluripotent stem cells (iPSCs) with isogenic control iPSCs
by: Anis Feki, et al.
Published: (2020-08-01)

Generation of a gene-corrected isogenic control iPSC line from cystic fibrosis patient-specific iPSCs homozygous for p.Phe508del mutation mediated by TALENs and ssODN
by: Sylvia Merkert, et al.
Published: (2017-08-01)

Maturing iPSC-Derived Cardiomyocytes
by: Bor Luen Tang
Published: (2020-01-01)

iPSC for modeling neurodegenerative disorders
by: Valeria Valadez-Barba, et al.
Published: (2020-12-01)

254 A systems genomics approach to identify novel drug targets of Ewing sarcoma through ancestry-informed human iPSC modeling
by: Rachel M Moss, et al.
Published: (2023-04-01)